Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials-Reference-Cited by-同舟云学术

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

Published:2022-06 Issue:10341 Volume:399 Page:2113-2128
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Danese Silvio,Vermeire Séverine,Zhou Wen,Pangan Aileen L,Siffledeen Jesse,Greenbloom Susan,Hébuterne Xavier,D'Haens Geert,Nakase Hiroshi,Panés Julian,Higgins Peter D R,Juillerat Pascal,Lindsay James O,Loftus Edward V,Sandborn William J,Reinisch Walter,Chen Min-Hu,Sanchez Gonzalez Yuri,Huang Bidan,Xie Wangang,Liu John,Weinreich Michael A,Panaccione Remo

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Ulcerative colitis;Ungaro;Lancet,2017

2. ACG clinical guideline: ulcerative colitis in adults;Rubin;Am J Gastroenterol,2019

3. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management;Harbord;J Crohns Colitis,2017

4. Ustekinumab as induction and maintenance therapy for ulcerative colitis;Sands;N Engl J Med,2019

5. Vedolizumab as induction and maintenance therapy for ulcerative colitis;Feagan;N Engl J Med,2013

Cited by 267 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease;Cytokine & Growth Factor Reviews;2024-10

2. Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management;World Journal of Gastroenterology;2024-09-21

3. The Successful Use of Upadacitinib as Monotherapy for Hidradenitis Suppurativa and Ulcerative Colitis in the Setting of Refractory Disease;Pediatric Dermatology;2024-09-11

5. Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib;Digestive Diseases and Sciences;2024-09-09